Skip to main content

Table 1 General characteristics of 320 metastatic PDAC patients

From: Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer

Characteristics All patients (N = 320) Elevated serum GGT
(GGT > 48 U/L, N = 183)
Normal serum GGT
(GGT ≤ 48 U/L, N = 137)
p value
Mean (SD)/Median (SD)/N (%) Mean (SD)/Median (SD)/N (%) Mean (SD)/Median (SD)/N (%)
Age at diagnosis (Years) 65.28 (10.05) a 65.93 (9.97) a 64.41 (10.14) a 0.18
Sex (Male) 158 (49.38) c 93 (50.82) c 65 (47.45) c 0.57
Palliative chemotherapy (Yes) 150 (46.88) c 63 (34.43) c 87 (63.50) c 10–6.5
Survival length (Days) 177 (231.93) b 138 (271.65) b 281 (234.19) b 10–6.0
Baseline serum indicators
 ALB (g/L) 37.00 (7.32) b 36.00 (6.96) b 39.30 (7.12) b 10–6.5
 TBIL (μmol/L) 15.40 (113.14) b 34.80 (137.81) b 11.20 (15.36) b 10−14
 ALT (U/L) 29.00 (107.87) b 58.00 (110.61) b 17.10 (91.23) b 10–8.1
 FPG (mmol/L) 6.67 (3.26) b 6.70 (3.78) b 6.42 (2.32) b 0.15
 NLR (Unit free) 4.46 (8.26) b 5.08 (8.13) b 3.74 (8.45) b 10–2.3
 GGT (U/L) 85.5 (393.02) b NA NA NA
  1. a Mean with standard deviation (SD)
  2. b Median with standard deviation (SD)
  3. c Frequency with proportion (%)
\